Kodiak Sciences Inc. (KOD)
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Address
1200 PAGE MILL RD
PALO ALTO, CA 94304
Founded
2009
Number of Employees
111
Website
http://www.kodiak.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)